Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0719926B2 - Photoelectric conversion device using antibody and method for manufacturing the same - Google Patents
[go: Go Back, main page]

JPH0719926B2 - Photoelectric conversion device using antibody and method for manufacturing the same - Google Patents

Photoelectric conversion device using antibody and method for manufacturing the same

Info

Publication number
JPH0719926B2
JPH0719926B2 JP63074604A JP7460488A JPH0719926B2 JP H0719926 B2 JPH0719926 B2 JP H0719926B2 JP 63074604 A JP63074604 A JP 63074604A JP 7460488 A JP7460488 A JP 7460488A JP H0719926 B2 JPH0719926 B2 JP H0719926B2
Authority
JP
Japan
Prior art keywords
photoelectric conversion
antibody
membrane
immobilized
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63074604A
Other languages
Japanese (ja)
Other versions
JPH01248569A (en
Inventor
正之 原
淳 三宅
杉生 川村
登 富塚
利和 真島
秀樹 豊玉
弘明 杉野
秀一 安食
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stanley Electric Co Ltd
Original Assignee
Stanley Electric Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanley Electric Co Ltd filed Critical Stanley Electric Co Ltd
Priority to JP63074604A priority Critical patent/JPH0719926B2/en
Publication of JPH01248569A publication Critical patent/JPH01248569A/en
Publication of JPH0719926B2 publication Critical patent/JPH0719926B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Light Receiving Elements (AREA)
  • Electroluminescent Light Sources (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、光電変換機能を有する蛋白質を含む脂質膜を
利用した光電変換装置とその製造方法に関し、特に光電
変換機能を有する蛋白質を含む脂質膜を基板上に固定化
した光電変換装置とその製造方法に関する。
TECHNICAL FIELD The present invention relates to a photoelectric conversion device using a lipid membrane containing a protein having a photoelectric conversion function and a method for producing the same, and particularly to a lipid containing a protein having a photoelectric conversion function. The present invention relates to a photoelectric conversion device having a film immobilized on a substrate and a method for manufacturing the photoelectric conversion device.

[従来の技術] 光電変換機能を有する蛋白質を含む脂質膜として,たと
えばチラコイド膜が知られている。植物、藍藻、光合成
細菌等の光合成能を有する細胞に含まれるチラコイド膜
は、光合成機能に関する蛋白質および脂質を含む生体膜
である。この種の膜は、方向性を持って配列した光合成
反応中心蛋白質複合体を有し、光を吸収した時、膜を挟
んで電位差を生じる能力を持つ。このため、光電変換素
子等の光電変換装置へのチラコイド膜の利用が期待され
ている。従来の調製方法によると、チラコイド膜は細胞
を破砕した後に微細な膜断片もしくは膜小胞として得ら
れる場合が多い。このような膜を挟んで生ずる電位差を
直接外部に取り出すことは困難であった。そこで測定の
場合も、螢光等を利用した間接的測定方法により、主と
して溶液状態での光電変換機能の研究が成されてきた
(たとえば,Methods in Enzymology 69巻、409−715頁
(1980年)Academic Press)。
[Prior Art] As a lipid membrane containing a protein having a photoelectric conversion function, for example, a thylakoid membrane is known. The thylakoid membrane contained in cells having photosynthetic ability such as plants, cyanobacteria, and photosynthetic bacteria is a biological membrane containing proteins and lipids related to photosynthetic function. This kind of membrane has a photosynthetic reaction center protein complex arranged in a directional manner, and has the ability to generate a potential difference across the membrane when absorbing light. Therefore, the thylakoid film is expected to be used in a photoelectric conversion device such as a photoelectric conversion element. According to conventional preparation methods, thylakoid membranes are often obtained as fine membrane fragments or membrane vesicles after disrupting cells. It was difficult to directly take out the potential difference generated by sandwiching such a film. Therefore, also in the case of measurement, research on the photoelectric conversion function in a solution state has mainly been conducted by an indirect measurement method using fluorescence (for example, Methods in Enzymology 69, 409-715 (1980). Academic Press).

[発明が解決しようとする問題点] 光電変換機能を有する蛋白質を含む脂質膜を光電変換素
子として利用するには、膜の表裏を揃えて固定化し,膜
を挟んで生ずる電気的信号を取り出す技術の開発が望ま
れている。電気的信号はたとえば電流,ないしは電位差
である。
[Problems to be Solved by the Invention] In order to use a lipid membrane containing a protein having a photoelectric conversion function as a photoelectric conversion element, a technique is used in which the front and back surfaces of the membrane are aligned and fixed, and an electrical signal generated by sandwiching the membrane is taken out. Development is desired. The electrical signal is, for example, a current or a potential difference.

本発明の目的は電極を備えた基板上に光電変換機能を有
する蛋白質を含む脂質膜を方向性をもって固定化した光
電変換装置を提供することである。
An object of the present invention is to provide a photoelectric conversion device in which a lipid film containing a protein having a photoelectric conversion function is directionally immobilized on a substrate provided with electrodes.

本発明の他の目的は基板上に光電変換機能を有する蛋白
質を含む脂質膜を方向性を持って固定化し,光電変換装
置を製造する方法を提供することである。
Another object of the present invention is to provide a method for producing a photoelectric conversion device by directionally immobilizing a lipid film containing a protein having a photoelectric conversion function on a substrate.

[問題点を解決するための手段] 光電変換機能を有する蛋白質を含む脂質膜の特定の部位
に対する抗体を準備し、電極を備えた基板上に固定化
し、この基板上に光電変換機能を有する蛋白質を含む脂
質膜を方向性を持って固定化する。
[Means for Solving Problems] An antibody against a specific site of a lipid membrane containing a protein having a photoelectric conversion function is prepared, immobilized on a substrate provided with an electrode, and a protein having a photoelectric conversion function is provided on the substrate. Immobilize the lipid membrane containing directionally.

光電変換機能を有する蛋白質を含む脂質膜として,たと
えば、植物の葉緑体,藍藻,光合成細菌等に細胞に含ま
れるチラコイド膜が用いられるが,チラコイド膜中でも
ロドシュードモナス・ビリジス(ATCC19567),ロドバ
クタースフェロイデス(ATCC17023)等の細胞を破砕し
て得られる標品であるクロマトホア膜は好適な材料であ
る。
As a lipid membrane containing a protein having a photoelectric conversion function, for example, a thylakoid membrane contained in cells of plant chloroplasts, cyanobacteria, photosynthetic bacteria, etc. is used. A chromatophore membrane, which is a standard product obtained by disrupting cells such as Spheroides (ATCC17023), is a suitable material.

電極には,インジウム−錫・酸化物(ITO),酸化錫(S
nO2),金属蒸着膜,半導体等を用いることができる。
電極基板の作成は,たとえば,真空蒸着等の方法によ
り,基板上に導電性膜を形成すること等により行うこと
ができる。
Indium-tin oxide (ITO), tin oxide (S
nO2), metal vapor deposition film, semiconductor, etc. can be used.
The electrode substrate can be prepared by forming a conductive film on the substrate by a method such as vacuum deposition.

電極基板に対する抗体の固定化は,たとえば,化学結
合,吸着等によって行うことができる。
The antibody can be immobilized on the electrode substrate by, for example, chemical bonding, adsorption or the like.

抗原抗体反応により脂質膜と抗体とを結合させることが
できる。
The lipid membrane and the antibody can be bound by the antigen-antibody reaction.

このようにして,光電変換機能を有する蛋白質を含む脂
質膜を,一定の方向性を持って基板上に固定化できる。
In this way, the lipid membrane containing the protein having the photoelectric conversion function can be immobilized on the substrate in a certain direction.

また,このような操作を繰り返すことによって,積層化
を行うこともできる。
Further, by repeating such an operation, stacking can be performed.

[作用] 抗体は抗原を認識して、抗原−抗体反応を起こして抗原
と結合する。光電変換機能を有する蛋白質を含む脂質膜
の特定の部位に対する抗体を基板上に固定化すると、そ
の上に光電変換機能を有する蛋白質を含む脂質膜(抗原
を含む)を方向性を持って固定化することができる。
[Action] The antibody recognizes the antigen, causes an antigen-antibody reaction, and binds to the antigen. When an antibody against a specific part of a lipid membrane containing a protein having a photoelectric conversion function is immobilized on a substrate, a lipid membrane (including an antigen) containing a protein having a photoelectric conversion function is directionally immobilized on the substrate. can do.

[実施例] 光電変換機能を有する蛋白質を含む脂質膜の材料はたと
えばチラコイド膜であり、植物、藍藻、光合成細菌等の
細胞より調製することができる。中でも光合成細菌ロド
シュードモナスビリジス(ATCC19567)、ロドバクター
スフェロイデス(ATCC17023)等の細胞を破砕して得ら
れるクロマトホア膜は、好適な材料である。これらのク
ロマトホア膜において、光合成を行う光合成反応中心の
蛋白質複合体は膜内在蛋白質である。そのサブユニット
には、L、M両サブユニットのように脂質膜に埋まった
部分の多いサブユニットと、Cサブユニット,Hサブユニ
ットのように比較的脂質膜外の部分が多いサブユニット
が存在する。
[Example] The material for the lipid membrane containing a protein having a photoelectric conversion function is, for example, a thylakoid membrane, which can be prepared from cells such as plants, cyanobacteria, and photosynthetic bacteria. Among them, a chromatophore membrane obtained by crushing cells such as photosynthetic bacteria Rhodopseudomonas viridis (ATCC19567) and Rhodobacter sphaeroides (ATCC17023) is a preferable material. In these chromatophore membranes, the protein complex at the photosynthetic reaction center that performs photosynthesis is an integral membrane protein. Among the subunits, there are subunits that have a large portion embedded in the lipid membrane, such as both L and M subunits, and subunits that have a relatively large portion outside the lipid membrane, such as the C subunit and H subunit. To do.

生体、特に高等動物の体内に、異物が侵入したとき、生
体はこの異物をしりぞけて体を守ろうとする。この免疫
のしくみの1つとして異物を食べて分解してしまう食細
胞の働きがある。その場合、異物をいちはやく認識して
これと結合し,異物が食細胞によって食べられるのを助
ける役をするのが抗体である。抗原となる異物と抗体と
の結合を抗原抗体反応と呼ぶ。抗体生産を促すものが抗
原であるが、蛋白質や脂質は、多糖類、ある種の非生物
的ポリマ等と共に抗原となる。抗体の化学的実体として
は、γ−グロブリンと呼ばれる一群の蛋白質分子が知ら
れている。γ−グロブリンにはIgG、EgE、IgM等いくつ
かの種類がある。たとえば、IgGは分子量約15万の蛋白
質である。
When a foreign body enters the body of a living body, in particular a higher animal, the living body tries to protect the body by repelling this foreign body. One of the mechanisms of this immunity is the function of phagocytic cells that eat foreign substances and decompose them. In that case, it is the antibody that recognizes and binds to the foreign substance as soon as possible, and helps the foreign substance to be eaten by the phagocytes. The binding between a foreign substance serving as an antigen and an antibody is called an antigen-antibody reaction. Antigens stimulate the production of antibodies, but proteins and lipids become antigens along with polysaccharides, certain abiotic polymers, and the like. As a chemical entity of an antibody, a group of protein molecules called γ-globulin are known. There are several types of γ-globulin such as IgG, EgE, and IgM. For example, IgG is a protein with a molecular weight of about 150,000.

光電変換機能を有する蛋白質を含む脂質膜の特定の部位
に対する抗体を作り、利用することによって、脂質膜を
方向性をもって固定化する。好ましくは脂質膜外の部分
が多いサブユニットの内で、さらに膜の片側に位置する
部位に対する抗体を準備し、基板表面上に、化学結合,
吸着等によって固定化する。
By preparing and utilizing an antibody against a specific site of a lipid membrane containing a protein having a photoelectric conversion function, the lipid membrane is directionally immobilized. Preferably, an antibody against a site located on one side of the membrane among the subunits having a large portion outside the lipid membrane is prepared, and chemically bound to the surface of the substrate,
Immobilize by adsorption.

ホルムアルデヒド等の架橋試薬処理により、電極を備え
た基板上に残基を付けて抗体を結合させる場合、共有結
合をすると考えられる。ニトロセルロース膜等には抗体
分子が非共有結合的に吸着すると考えられる。
When a residue is attached to an antibody-attached substrate by a treatment with a crosslinking reagent such as formaldehyde to bind the antibody, covalent bond is considered to occur. It is considered that antibody molecules are non-covalently adsorbed on the nitrocellulose membrane or the like.

抗体を結合させた基板上にクロマトホア膜を接触させる
と、特異的な抗原−抗体反応によって、クロマトホア膜
が方向性を持って強く結合する。
When the chromatophore membrane is brought into contact with the substrate to which the antibody is bound, the chromatophore membrane is directionally and strongly bound by a specific antigen-antibody reaction.

以下に図面を参照して本発明をさらに詳細に説明する。Hereinafter, the present invention will be described in more detail with reference to the drawings.

[クロマトホア膜の調製] 光合成細菌であるロドシュードモナスビリジス(ATCC19
567)を、嫌気状態で、光照射下、30℃で培養した。得
られた菌体より以下の手順によってクロマトホア膜を調
製した。すなわち、菌体をフレンチプレスによって破砕
し、庶糖密度勾配遠心等の遠心分画法によって膜小胞を
調製し、10mMのトリス塩酸Tris-HCl(pH8.2)水溶液に
透析した(Arch.Biochem.Biophys.,223巻282−290頁(1
979年))。このようにして第1図(A)に示すような
クロマトホア膜を調製した。脂質膜2に光合成反応中心
の蛋白質複合体1が埋め込まれた構造を有している。
[Preparation of chromatophore membrane] Rhodopseudomonas viridis (ATCC19) which is a photosynthetic bacterium
567) was cultured in the anaerobic state at 30 ° C. under light irradiation. A chromatophore membrane was prepared from the obtained bacterial cells by the following procedure. That is, the cells were disrupted by a French press, membrane vesicles were prepared by a centrifugal fractionation method such as sucrose density gradient centrifugation, and dialyzed against 10 mM Tris-HCl Tris-HCl (pH 8.2) aqueous solution (Arch.Biochem. Biophys., 223, 282-290 (1
979)). Thus, a chromatophore membrane as shown in FIG. 1 (A) was prepared. It has a structure in which the protein complex 1 of the photosynthetic reaction center is embedded in the lipid membrane 2.

[抗体の作成] クロマトホア膜懸濁液(A1020=100)に20%N,N-ジメチ
ルドデシルアミン−N−オキシド(N,N-dimethyldodecy
lamine-N-oxide,LDAO)を加えて可溶化し、セファロー
ス(Sepharose)CL-6Bゲル過を用いて光合成反応中心
蛋白質を精製する。得られた精製標品をドデシル硫酸ナ
トリウム(SDS)−ポリアクリルアミドゲル電気泳動に
かけ(Nature,227巻 680-685頁(1970))、Hサブユニ
ットおよびCサブユニットのバンドをそれぞれ切り出し
て、蛋白質を抽出、回収する。この様にして精製された
サブユニット蛋白質3-5mgをウサギに免疫して各サブユ
ニットに対する抗血清を得る。この抗血清からγ−グロ
ブリンを精製する。γ−グロブリンの精製には必要に応
じて塩析法、抗原吸収法、各種カラムクロマトグラフィ
ー等を用いることができる。本実施例では,硫酸アンモ
ニウム塩析法を用いた。
[Preparation of antibody] 20% N, N-dimethyldodecylamine-N-oxide (N, N-dimethyldodecy) was added to the chromatophore membrane suspension (A1020 = 100).
lamine-N-oxide, LDAO) is added for solubilization, and the photosynthetic reaction center protein is purified using Sepharose CL-6B gel. The obtained purified sample was subjected to sodium dodecyl sulfate (SDS) -polyacrylamide gel electrophoresis (Nature, Vol. 227, pages 680-685 (1970)), and the H subunit and C subunit bands were respectively cut out to obtain the protein. Extract and collect. Rabbits are immunized with 3-5 mg of the subunit protein thus purified to obtain antisera against each subunit. Γ-globulin is purified from this antiserum. For purification of γ-globulin, a salting-out method, an antigen absorption method, various column chromatography and the like can be used if necessary. In this example, the ammonium sulfate salting-out method was used.

[抗体の基板表面への固定化] 固定化の基板として、ガラス基板6に酸化錫(SnO2),I
TO,金等の導電性物質を蒸着して薄膜状電極5としたも
のを用いる。第1図(B)に示すようにSnO2電極5の表
面に蛋白質吸着能力の高いニトロセルロース等の物質で
さらに薄膜4を作り,抗体を吸着させる。
[Immobilization of Antibody on Substrate Surface] As an immobilization substrate, tin oxide (SnO2),
A thin film electrode 5 is formed by depositing a conductive material such as TO and gold. As shown in FIG. 1 (B), a thin film 4 is further formed on the surface of the SnO2 electrode 5 by using a substance such as nitrocellulose having a high protein adsorbing ability to adsorb the antibody.

このような薄膜の作成については,ニトロセルロースの
0.002%酢酸アミル溶液(コロジオン溶液)50マイクロ
リットルを2平方センチメートルの電極面上にのせて乾
燥固化させる方法,および2%コロジオン溶液20マイク
ロリットルを水面上に展開し,溶媒を蒸発させて固化し
た薄膜を電極面に圧着する方法等を用いることができ
る。
For making such a thin film,
A method in which 50 microliters of 0.002% amyl acetate solution (colodion solution) is placed on an electrode surface of 2 square centimeters to dry and solidify, and a thin film in which 20 microliters of 2% collodion solution is spread on the water surface and the solvent is evaporated to solidify It is possible to use a method of pressure-bonding to the electrode surface.

これらの電極を燐酸緩衝液(pH7.4)を含む生理的食塩
水(PBS)で洗浄後,20μg/mlの抗体を含むPBSで30℃で2
0分処理を行い,抗体分子3を吸着させる。
These electrodes were washed with physiological saline (PBS) containing phosphate buffer (pH 7.4) and then with PBS containing 20 μg / ml antibody at 30 ° C for 2 days.
Treatment is performed for 0 minutes to adsorb the antibody molecule 3.

上述のニトロセルロース膜を用いた固定化は各種材料か
らなる基板への抗体の固定化に広く用いることができ
る。
The above-mentioned immobilization using a nitrocellulose membrane can be widely used for immobilizing an antibody on a substrate made of various materials.

電極の素材によってはホルムアルデヒド,グルタルアル
デヒド等の架橋試薬を用いて残基を形成し、抗体分子を
電極平面に化学的に結合させることも可能である。
Depending on the material of the electrode, it is also possible to form a residue using a cross-linking reagent such as formaldehyde or glutaraldehyde to chemically bond the antibody molecule to the electrode plane.

[クロマトホア膜の固体表面への固定化] 抗体を固定化したガラス基板をクロマトホア膜(A1020
=5.0)を含むPBSで30℃で20分処理する。反応後PBSで
洗浄して未結合のクロマトホア膜を除く。以上の操作に
より第1図(C)に示すようにクロマトホア膜9を固定
化できる。さらにこの後1.7%ホルムアルデヒドを含むP
BSで30℃で30分処理して,結合したクロマトホア膜を固
定化した。第2図にPBS中で測定した固定化したクロマ
トホア膜の光吸収スペクトルを示す。このようにクロマ
トホア膜を固定化した基板を1%牛血清アルブミン(BS
A)水溶液に浸した後,乾燥させる。
[Immobilization of chromatophore membrane on solid surface] A glass substrate on which an antibody is immobilized is used as a chromatophore membrane (A1020).
= 5.0) in PBS at 30 ℃ for 20 minutes. After the reaction, wash with PBS to remove the unbound chromatophore membrane. By the above operation, the chromatophore membrane 9 can be immobilized as shown in FIG. 1 (C). After this, P containing 1.7% formaldehyde
The bound chromatophore membrane was immobilized by treatment with BS at 30 ° C for 30 minutes. Figure 2 shows the optical absorption spectrum of the immobilized chromatophore membrane measured in PBS. The substrate on which the chromatophore membrane was immobilized in this manner was used as a 1% bovine serum albumin (BS
A) Soak in aqueous solution and dry.

また,固定化クロマトホア膜の上に,コロジオン薄膜を
重ね,その上に改めて固定化を行うことにより,第1図
(E)に示すように,複数回の積層も可能である。
Also, by stacking a collodion thin film on the immobilized chromatophore membrane and immobilizing it again, it is possible to stack a plurality of times as shown in FIG. 1 (E).

第1図(D)に示すように,抗体7がクロマトホア膜の
反対側の部位に対するものであれば,クロマトホア膜9
は第1図(C)の場合とは逆向きに固定化する。
As shown in FIG. 1 (D), if the antibody 7 is directed to the opposite side of the chromatophore membrane, the chromatophore membrane 9
Is fixed in the opposite direction to the case of FIG. 1 (C).

上述のような固定化法により、チラコイド膜を方向性を
もって固定化できる。積層することもできる。チラコイ
ド膜のみに限らず、蛋白質を含む脂質膜を方向性を持っ
て固定化できるものと考えられる。
By the immobilization method as described above, the thylakoid film can be directionally immobilized. It can also be laminated. It is considered that not only thylakoid membranes but also lipid membranes containing proteins can be immobilized in a directional manner.

[光電応答の検出] 基板上に固定化した脂質膜上に,対極となる電極を取り
付けて,光刺激を与え,光電応答による両電極間の電気
信号を取り出すことができる。たとえば,電位,電流の
変化を測定する。対極は,光電変換層である脂質膜の表
面に水銀玉を載せる,金属薄膜を圧着する,金属薄膜を
蒸着する等の方法で形成できる。光刺激の光源は,太陽
光等自然のものでもよいし,ストロボランプ,発光ダイ
オード(LED),レーザ,アーク燈等でもよい。
[Detection of photoelectric response] An electrode serving as a counter electrode can be attached on a lipid membrane immobilized on a substrate to apply a light stimulus, and an electric signal between both electrodes due to photoelectric response can be extracted. For example, measure changes in potential and current. The counter electrode can be formed by a method such as placing a mercury ball on the surface of the lipid film which is the photoelectric conversion layer, pressing a metal thin film, or vapor depositing a metal thin film. The light source of the light stimulus may be natural light such as sunlight, strobe lamp, light emitting diode (LED), laser, arc lamp, or the like.

第3図に,光電変換装置の光電応答検出系の概略を示
す。ガラス基板12上のSnO2電極11上にニトロセルロース
薄膜10を介してクロマトホア膜層9を固定化,積層す
る。その上に,水銀玉を載せる等の方法で対極8を作成
する。
FIG. 3 shows an outline of the photoelectric response detection system of the photoelectric conversion device. The chromatophore membrane layer 9 is fixed and laminated on the SnO2 electrode 11 on the glass substrate 12 via the nitrocellulose thin film 10. The counter electrode 8 is created by a method such as placing a mercury ball on it.

図中下側より,ストロボランプ,LED等の光源13からの光
刺激をガラス基板12、SnO2電極11、ニトロセルロース薄
膜10を通してクロマトホア膜層9に与える。光刺激によ
って両電極8、11間に生じる電位変化を導線14、15で取
り出し、差動アンプ16を介してオシロスコープ17で観察
した。
From the lower side in the figure, a light stimulus from a light source 13 such as a strobe lamp or an LED is applied to the chromatophore membrane layer 9 through the glass substrate 12, the SnO2 electrode 11, and the nitrocellulose thin film 10. The change in electric potential generated between the electrodes 8 and 11 by the light stimulation was taken out through the conductors 14 and 15 and observed by the oscilloscope 17 via the differential amplifier 16.

第4図に光刺激に対する光電変換装置の電位応答の例を
示す。ストロボランプ光の刺激に対して,ミリ秒以下の
速い応答の立ち上がりがみられた。本例においては抗H
サブユニット抗体をもちいて,1回固定化を行った光電変
換層を用いた。
FIG. 4 shows an example of the potential response of the photoelectric conversion device to the optical stimulus. A rapid rise of a millisecond or less was observed in response to the stimulus of strobe lamp light. In this example, anti-H
The photoelectric conversion layer was immobilized once using the subunit antibody.

[発明の効果] 光電変換機能を有する蛋白質を含む脂質膜を方向性をも
って固定化できる。
[Advantages of the Invention] A lipid membrane containing a protein having a photoelectric conversion function can be immobilized in a directional manner.

これにより光電変換装置が実現できる。As a result, a photoelectric conversion device can be realized.

【図面の簡単な説明】[Brief description of drawings]

第1図はクロマトホア膜の固定化を示す該略図であり、 (A)はクロマトホア膜、 (B)はニトロセルロース薄膜を張った電極上に抗Hサ
ブユニット抗体を吸着させた場合, (C)は(B)にクロマトホア膜を固定化した場合, (D)は抗Cサブユニット抗体を用いてクロマトホア膜
を固定化した場合, (E)は2回固定化積層した場合を示す。 第2図はSnO2電極上にニトロセルロース薄膜を張り,ク
ロマトホア膜を1回固定化後,PBS中にて測定した吸収ス
ペクトルである。 第3図は光電変換装置の光電応答検出系の概略図であ
る。 第4図はストロボランプ光の光刺激に対する光電変換装
置の電位応答で,抗Hサブユニット抗体を用いてクロマ
トホア膜1回固定化後の光電変換層を用いて検出した。 符号の説明 1……光合成反応中心蛋白質複合体 2……脂質膜 3……ニトロセルロース薄膜に吸着された抗Hサブユニ
ット抗体 4……ニトロセルロース薄膜 5……SnO2電極 6……ガラス基板 7……抗Cサブユニット抗体 8……対極となる電極 9……固定化積層されたクロマトホア膜層 10……ニトロセルロース薄膜 11……SnO2電極 12……ガラス基板 13……光源 14……対極に接続された導線 15……SnO2電極に接続された導線 16……差動アンプ 17……オシロスコープ
FIG. 1 is a schematic diagram showing immobilization of a chromatophore membrane, where (A) is a chromatophore membrane, (B) is the case where an anti-H subunit antibody is adsorbed on an electrode coated with a nitrocellulose thin film, (C) Shows the case where the chromatophore membrane is immobilized on (B), (D) shows the case where the chromatophore membrane is immobilized using the anti-C subunit antibody, and (E) shows the case where the layer is immobilized twice. Figure 2 shows the absorption spectrum measured in PBS after a nitrocellulose thin film was placed on the SnO2 electrode and the chromatophore film was immobilized once. FIG. 3 is a schematic diagram of a photoelectric response detection system of the photoelectric conversion device. FIG. 4 shows the potential response of the photoelectric conversion device to the photostimulation of strobe lamp light, which was detected using the photoelectric conversion layer after the chromatophore membrane was immobilized once using the anti-H subunit antibody. Explanation of symbols 1 …… Photosynthetic reaction center protein complex 2 …… Lipid membrane 3 …… Anti-H subunit antibody adsorbed on nitrocellulose thin film 4 …… Nitrocellulose thin film 5 …… SnO2 electrode 6 …… Glass substrate 7 ・ ・ ・… Anti-C subunit antibody 8 …… An electrode that serves as the counter electrode 9 …… Immobilized and laminated chromatophore membrane layer 10 …… Nitrocellulose thin film 11 …… SnO2 electrode 12 …… Glass substrate 13 …… Light source 14 …… Connected to the counter electrode Conductor 15 …… Conductor connected to SnO2 electrode 16 …… Differential amplifier 17 …… Oscilloscope

───────────────────────────────────────────────────── フロントページの続き (72)発明者 川村 杉生 茨城県つくば市東1丁目1番3号 工業技 術院微生物工業技術研究所内 (72)発明者 富塚 登 茨城県つくば市東1丁目1番3号 工業技 術院微生物工業技術研究所内 (72)発明者 真島 利和 茨城県つくば市梅園1丁目1番4号 工業 技術院電子技術総合研究所内 (72)発明者 豊玉 秀樹 茨城県つくば市東光台5丁目9番5号 ス タンレー電気株式会社筑波研究所内 (72)発明者 杉野 弘明 茨城県つくば市東光台5丁目9番5号 ス タンレー電気株式会社筑波研究所内 (72)発明者 安食 秀一 茨城県つくば市東光台5丁目9番5号 ス タンレー電気株式会社筑波研究所内 (56)参考文献 特開 昭63−295600(JP,A) ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Sugio Kawamura 1-3-1, Higashi Tsukuba, Ibaraki Prefecture Institute of Microbial Technology, Industrial Technology Institute (72) Noboru Tomizuka 1-3-3 East, Tsukuba, Ibaraki (72) Inventor Toshikazu Majima, 1-4 Umezono, Tsukuba-shi, Ibaraki Institute of Electronic Technology Research Institute, Industrial Technology Institute (72) Hideki Toyoda 5-chome, Tokodai, Tsukuba, Ibaraki Prefecture 9-5 Stanley Electric Co., Ltd. Tsukuba Research Center (72) Inventor Hiroaki Sugino 5-9-5 Tokodai, Tsukuba City, Ibaraki Prefecture Stanley Electric Co., Ltd. Tsukuba Research Center (72) Inventor Shuichi Aji, East Tsukuba City, Ibaraki Prefecture 5-9-5 Hikaridai, Stanley Electric Co., Ltd., Tsukuba Research Laboratory (56) References JP-A-63-295600 JP, A)

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】第1の電極部を有する基板と、 該第1の電極部上に固定された抗体と、 光合成能を有する細胞より調製された、脂質と光電変換
機能を有する蛋白質とを含む脂質膜であって、その特定
の部位が抗原として機能し、該抗体と抗原抗反応により
結合している脂質膜で形成された光電変換層と、 該光電変換層を挟んで、第1の電極部と対向するように
該光電変換層上に形成された第2の電極部と を有し、 該抗体と該抗体が固定されている該第1の電極の間に
は、蛋白質や脂質が存在しない光電変換装置。
1. A substrate having a first electrode portion, an antibody immobilized on the first electrode portion, a lipid prepared from cells having photosynthetic ability, and a protein having a photoelectric conversion function. A photoelectric conversion layer formed of a lipid film, a specific portion of which functions as an antigen and is bound to the antibody by an antigen antireaction, and a first electrode with the photoelectric conversion layer sandwiched therebetween. And a second electrode portion formed on the photoelectric conversion layer so as to face the portion, and a protein or lipid is present between the antibody and the first electrode to which the antibody is immobilized. Not photoelectric conversion device.
【請求項2】光電変換機能を有する蛋白質を含む脂質膜
の特定の部位に対する抗体を基板上に固定化する工程
と、 抗体を固定した該基板に光電変換機能を有する蛋白質を
含む脂質膜を固定化する工程と を含む光電変換装置の製造方法。
2. A step of immobilizing an antibody against a specific portion of a lipid membrane containing a protein having a photoelectric conversion function on a substrate, and a lipid membrane containing a protein having a photoelectric conversion function is immobilized on the substrate on which the antibody is immobilized. A method for manufacturing a photoelectric conversion device, including the step of:
JP63074604A 1988-03-30 1988-03-30 Photoelectric conversion device using antibody and method for manufacturing the same Expired - Lifetime JPH0719926B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63074604A JPH0719926B2 (en) 1988-03-30 1988-03-30 Photoelectric conversion device using antibody and method for manufacturing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63074604A JPH0719926B2 (en) 1988-03-30 1988-03-30 Photoelectric conversion device using antibody and method for manufacturing the same

Publications (2)

Publication Number Publication Date
JPH01248569A JPH01248569A (en) 1989-10-04
JPH0719926B2 true JPH0719926B2 (en) 1995-03-06

Family

ID=13551934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63074604A Expired - Lifetime JPH0719926B2 (en) 1988-03-30 1988-03-30 Photoelectric conversion device using antibody and method for manufacturing the same

Country Status (1)

Country Link
JP (1) JPH0719926B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859538A (en) * 1986-11-20 1989-08-22 Ribi Hans O Novel lipid-protein compositions and articles and methods for their preparation

Also Published As

Publication number Publication date
JPH01248569A (en) 1989-10-04

Similar Documents

Publication Publication Date Title
US6342389B1 (en) Modified phycobilisomes and uses therefore
Turkova Oriented immobilization of biologically active proteins as a tool for revealing protein interactions and function
Kieda et al. Lymphocyte membrane lectins. Direct visualization by the use of fluoresceinyl-glycosylated cytochemical markers
US4092116A (en) Method for binding antibodies to a surface such that they remain active
Irons et al. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography
Burke The purification of interferon
JPS5840143B2 (en) Labeling aid
Breitwieser et al. 2-D protein crystals as an immobilization matrix for producing reaction zones in dipstick-style immunoassays
WO1996006858A1 (en) (1→3)-β-D-GLUCAN-BINDING PROTEIN, ANTIBODY THAT RECOGNIZES THE PROTEIN, AND USE OF THE PROTEIN AND ANTIBODY
US4247452A (en) Purification of pertussis haemagglutinins
Natori et al. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, Meth-A
Reiss et al. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes
KoLBERG et al. Properties of a lectin purified from the seeds of Cicer arietinum
AU4290185A (en) Bispecific antibody determinants
JPH0719927B2 (en) Photoelectric conversion device using avidin-biotin system and manufacturing method thereof
Howe et al. Immunochemical study of hemoglobin-free human erythrocyte membranes
JPH0719926B2 (en) Photoelectric conversion device using antibody and method for manufacturing the same
Halbert et al. THE USE OF PRECIPITIN ANALYSIS IN AGAR FOR THE STUDY OF HUMAN STREPTOCOCCAL INFECTIONS: IV. FURTHER OBSERVATIONS ON THE PURIFICATION OF GROUP A EXTRACELLULAR ANTIGENS
Güttler et al. Changes in lipid pattern of HeLa cells exposed to immunoglobulin G and complement
Howe et al. Studies on a hemagglutinin from the lichen Parmelia michauxiana
JP2632063B2 (en) Color image light receiving element
Fang et al. Physiochemical characterization of proteolytic cleavage fragments of bovine colostral immunoglobulin G1 (IgG1)
Palmer Affinity chromatography: Interactions between sepharose-linked and soluble γ-globulin
EP0532430A1 (en) Reagent to identify bacteria of the species Staphylococcus aureus
Cherniak et al. Immunochemistry of the capsular polysaccharides from Clostridium perfringens: selected Hobbs strains 1, 5, 9, and 10

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term